To order by mail, send check/money order payable to:
PO Box 2471
Hillsboro, OR 97123
* If you live outside the
. check to see if this product is legal in your country. If you are under medical supervision, consult with your physician before
taking product. This information presented is intended to be used for
educational purposes only. The statements made have not been evaluated
by the Food and Drug Administration (.). These products are not intended
to diagnose, treat, cure or prevent any condition or disease. Please consult
with your own physician or health care practitioner regarding any suggestions
and recommendations made.
Buy ecdysterone an herbal , legal anabolic , steroid replacement for muscle growth and fat loss .
In clinical studies, cyproterone was found to be far less potent and effective as an antiandrogen relative to CPA, likely in significant part due to its lack of concomitant antigonadotropic action.  Cyproterone was studied as a treatment for precocious puberty by Bierich (1970, 1971), but no significant improvement was observed.  In men, 100 mg/day cyproterone proved to be rather ineffective in treating acne , which was hypothesized to be related to its progonadotropic effects in males and counteraction of its antiandrogen activity.   In women however, in whom the drug has no progonadotropic activity, 100–200 mg/day oral cyproterone was effective in reducing sebum production in all patients as early as 2–4 weeks following the start of treatment.  In contrast, topical cyproterone was far less effective and barely outperformed placebo .  In addition, another study showed disappointing results with 100 mg/day cyproterone for reducing sebum production in women with hyperandrogenism .  Similarly, the drug showed disappointing results in the treatment of hirsutism , with a distinct hair reduction occurring in only a limited percentage of cases.  In the same study, the reduction of acne was better, but clearly inferior to that produced by CPA, and only the improvement in seborrhea was regarded as satisfactory.  The addition of an oral contraceptive to cyproterone resulted in a somewhat better improvement in acne and seborrhea relative to cyproterone alone.  According to Jacobs (1979), “[cyproterone] proved to be without clinical value for reasons that cannot be discussed here.”  In any case, cyproterone has been well-tolerated by patients in dosages of up to 300 mg/day. 
Oral exemestane 25 mg/day for 2–3 years of adjuvant therapy was generally more effective than 5 years of continuous adjuvant tamoxifen in the treatment of postmenopausal women with early-stage estrogen receptor-positive/unknown receptor status breast in a large well-designed [ citation needed ] trial. Preliminary data from the open-label TEAM trial comparing exemestane with tamoxifen indicated in 2009 that exemestane 25 mg/day is also effective in the primary adjuvant treatment of early-stage breast cancer in postmenopausal women.